These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9266487)

  • 1. In vitro reactivity of the antineoplastic drug carmustin and acrolein with model peptides.
    Carbone V; Salzano A; Pucci P; Fiume I; Pocsfalvi G; Sannolo N; Di Landa G; Malorni A
    J Pept Res; 1997 Jun; 49(6):586-95. PubMed ID: 9266487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
    Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of glutathione-mediated DNA damage by the antineoplastic agent 1,3-bis(2-chloroethyl)-N-nitrosourea.
    Stahl W; Lenhardt S; Przybylski M; Eisenbrand G
    Chem Res Toxicol; 1992; 5(1):106-9. PubMed ID: 1581526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of interaction of styrene oxide with angiotensin by mass spectrometry.
    Ferranti P; Carbone V; Sannolo N; Fiume I; Milone A; Ruoppolo M; Gallo M; Malorni A
    Carcinogenesis; 1992 Aug; 13(8):1397-401. PubMed ID: 1499089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein modification by acrolein: formation and stability of cysteine adducts.
    Cai J; Bhatnagar A; Pierce WM
    Chem Res Toxicol; 2009 Apr; 22(4):708-16. PubMed ID: 19231900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry.
    Carini M; Aldini G; Beretta G; Arlandini E; Facino RM
    J Mass Spectrom; 2003 Sep; 38(9):996-1006. PubMed ID: 14505328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein.
    Furuhata A; Ishii T; Kumazawa S; Yamada T; Nakayama T; Uchida K
    J Biol Chem; 2003 Dec; 278(49):48658-65. PubMed ID: 14504272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA interchain cross-links formed by acrolein and crotonaldehyde.
    Kozekov ID; Nechev LV; Moseley MS; Harris CM; Rizzo CJ; Stone MP; Harris TM
    J Am Chem Soc; 2003 Jan; 125(1):50-61. PubMed ID: 12515506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 2'-deoxycytidine and 2'-deoxyuridine adducts formed in reactions with acrolein and 2-bromoacrolein.
    Chenna A; Iden CR
    Chem Res Toxicol; 1993; 6(3):261-8. PubMed ID: 8318647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchain cross-linking of DNA mediated by the principal adduct of acrolein.
    Kozekov ID; Nechev LV; Sanchez A; Harris CM; Lloyd RS; Harris TM
    Chem Res Toxicol; 2001 Nov; 14(11):1482-5. PubMed ID: 11712904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of adducts formed in reactions of acrolein with thymidine and calf thymus DNA.
    Pawłowicz AJ; Kronberg L
    Chem Biodivers; 2008 Jan; 5(1):177-88. PubMed ID: 18205121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterisation of acetaldehyde adducts formed by a synthetic peptide mimicking the N-terminus of the hemoglobin beta-chain under reducing and nonreducing conditions.
    Sillanaukee P; Hurme L; Tuominen J; Ranta E; Nikkari S; Seppä K
    Eur J Biochem; 1996 Aug; 240(1):30-6. PubMed ID: 8797832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs.
    Kaminskas LM; Pyke SM; Burcham PC
    Rapid Commun Mass Spectrom; 2007; 21(7):1155-64. PubMed ID: 17318925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity.
    Burcham PC; Fontaine FR; Kaminskas LM; Petersen DR; Pyke SM
    Mol Pharmacol; 2004 Mar; 65(3):655-64. PubMed ID: 14978244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Quantification of Acrolein-Induced Modifications in Hemoglobin by Mass Spectrometry─Effect of Cigarette Smoking.
    Chen HC; Cheng SW; Chen NY; Wu DC
    Chem Res Toxicol; 2022 Dec; 35(12):2260-2270. PubMed ID: 36367988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of acrolein adducts with 2'-deoxyadenosine in calf thymus DNA.
    Pawłowicz AJ; Munter T; Zhao Y; Kronberg L
    Chem Res Toxicol; 2006 Apr; 19(4):571-6. PubMed ID: 16608169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 3,N4-propanodeoxycytidine 5'-monophosphate formed by the reaction of acrolein with deoxycytidine 5'-monophosphate.
    Smith RA; Williamson DS; Cohen SM
    Chem Res Toxicol; 1989; 2(4):267-71. PubMed ID: 2519782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.
    Liu X; Lovell MA; Lynn BC
    Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry.
    Bouchon B; Klein M; Bischoff R; Van Dorsselaer A; Roitsch C
    Anal Biochem; 1997 Mar; 246(1):52-61. PubMed ID: 9056182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenging of Acrolein by Food-Grade Antioxidant Propyl Gallate in a Model Reaction System and Cakes.
    Wang J; Lu Y; Zheng T; Sang S; Lv L
    J Agric Food Chem; 2019 Aug; 67(31):8520-8526. PubMed ID: 31310120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.